Diagnosis of gastric submucosal tumors and estimation of malignant risk of GIST by endoscopic ultrasound. Comparison between B mode and contrast-harmonic mode



      standard B-mode EUS assessment and EUS-guided tissue acquisition present sub-optimal diagnostic yield in the differential diagnosis of gastric submucosal tumors (SMTs).


      to evaluate the performances of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) to differentiate gastric SMTs and predict malignancy risk of gastrointestinal stromal tumors (GIST).


      a retrospective analysis was performed retrieving consecutive patients with gastric SMTs who underwent EUS between 2009 and 2014. Patients with available EUS video recordings and histological diagnosis were included. De-identified videos were presented to experts who made a diagnosis on B-mode EUS and CH-EUS.


      fifty-four patients (29 female, 64-year-old) were included. Final diagnoses were 40 GISTs (8 high-grade), 9 leiomyomas, 5 rare SMTs. The sensitivity, specificity, and accuracy of B-mode and CH-EUS for the differential diagnosis of GIST were 95.0% vs. 85.0%, 57.1% for both techniques, and 85.2% vs. 77.8%, respectively. The sensitivity, specificity, and accuracy of B-mode and CH-EUS for the estimation of the malignancy GISTs risk were 62.5% vs. 100%, 83.3% vs. 82.1%, and 78.9% vs. 86.1%, respectively.


      CH-EUS showed better diagnostic performance than B-mode EUS in differentiating leiomyomas and risk stratification of GIST. When considering high-grade GISTs, the addition of CH-EUS allowed an improvement in diagnostic accuracy.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Miettinen M.
        • Sobin L.H.
        • Lasota J.
        Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.
        Am J Surg Pathol. 2005; 29: 52-68
        • Miettinen M.
        • Lasota J.
        Gastrointestinal stromal tumors: pathology and prognosis at different sites.
        Semin Diagn Pathol. 2006; 23: 70-83
        • Joensuu H.
        Risk stratification of patients diagnosed with gastrointestinal stromal tumor.
        Hum Pathol. 2008; 39: 1411-1419
        • Iorio N.
        • Sawaya R.A.
        • Friedenberg FK.
        Review article: the biology, diagnosis and management of gastrointestinal stromal tumors.
        Aliment Pharmacol Ther. 2014; 39: 1376-1386
        • Akahoshi K.
        • Oya M.
        • Koga T.
        • et al.
        Current clinical management of gastrointestinal stromal tumor.
        World J Gastroenterol. 2018; 24: 2806-2817
        • Kadkhodayan K.
        • Rafiq E.
        • Hawes RH.
        Endoscopic evaluation and management of gastric stromal tumors.
        Curr Treat Options Gastroenterol. 2017; 15: 691-700
        • Gress F.
        • Schmitt C.
        • Savides T.
        • et al.
        Interobserver agreement for EUS in the evaluation and diagnosis of submucosal masses.
        Gastrointest Endosc. 2001; 53: 71-76
        • Fusaroli P.
        • Kypraios D.
        • Eloubeidi M.A.
        • et al.
        Levels of evidence in endoscopic ultrasonography: a systematic review.
        Dig Dis Sci. 2012; 57: 602-609
        • Palazzo L.
        • Landi B.
        • Cellier C.
        • et al.
        Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours.
        Gut. 2000; 46: 88-92
        • Landi B.
        • Palazzo L.
        The role of endosonography in submucosal tumours.
        Best Pract Res Clin Gastroenterol. 2009; 23: 679-701
        • Facciorusso A.
        • Sunny S.P.
        • Del Prete V.
        • et al.
        Comparison between fine-needle biopsy and fine-needle aspiration for EUS-guided sampling of subepithelial lesions: a meta-analysis.
        Gastrointest Endosc. 2020; 91: 14-22
        • Dumonceau J.M.
        • Deprez P.H.
        • Jenssen C.
        • et al.
        Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - updated January 2017.
        Endoscopy. 2017; 49: 695-714
        • Kitano M.
        • Sakamoto H.
        • Kudo M.
        Contrast-enhanced endoscopic ultrasound.
        Dig Endosc. 2014; 26: 79-85
        • Bories E.
        • Caillol F.
        • Ratone J.P.
        • et al.
        Characterization of subepithelial lesions of the stomach and esophagus by contrast-enhanced EUS: a retrospective study.
        Endosc Ultrasound. 2019; 8: 43-49
        • Yang Y.T.
        • Shen N.
        • Ao F.
        • et al.
        Diagnostic value of contrast-enhanced harmonic endoscopic ultrasonography in predicting the malignancy potential of submucosal tumors: a systematic review and meta-analysis.
        Surg Endosc. 2020; 34: 3754-3765
        • Park H.Y.
        • Jeon S.W.
        • Lee H.S.
        • et al.
        Can contrast-enhanced harmonic endosonography predict malignancy risk in gastrointestinal subepithelial tumors?.
        Endosc Ultrasound. 2016; 5: 384-389
        • Sakamoto H.
        • Kitano M.
        • Matsui S.
        • et al.
        Estimation of malignant potential of GI stromal tumors by contrast-enhanced harmonic EUS (with videos).
        Gastrointest Endosc. 2011; 73: 227-237
        • Yamashita Y.
        • Kato J.
        • Ueda K.
        • et al.
        Contrast-enhanced endoscopic ultrasonography can predict a higher malignant potential of gastrointestinal stromal tumors by visualizing large newly formed vessels.
        J Clin Ultrasound. 2015; 43: 89-97
        • Zhao Y.
        • Qian L.
        • Li P.
        • et al.
        The diagnostic value of endoscopic ultrasonography and contrast-enhanced harmonic endoscopic ultrasonography in gastrointestinal stromal tumors.
        Endosc Ultrasound. 2016; 5: 111-117
        • Kamata K.
        • Takenaka M.
        • Kitano M.
        • et al.
        Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of submucosal tumors of the upper gastrointestinal tract.
        J Gastroenterol Hepatol. 2017; 32: 1686-1692
        • Cho I.R.
        • Park J.C.
        • Roh Y.H.
        • et al.
        Noninvasive prediction model for diagnosing gastrointestinal stromal tumors using contrast-enhanced harmonic endoscopic ultrasound.
        Dig Liv Dis. 2019; 51: 985-992
        • Petersen F.
        • et al.
        Contrast-enhanced harmonic endoscopic ultrasound is able to discriminate benign submucosal lesions from gastrointestinal stromal tumors.
        Scand J Gastroenterol. 2012; 47: 1515-1520
        • Fletcher C.D.
        • Berman J.J.
        • Corless C.
        • et al.
        Diagnosis of gastrointestinal stromal tumors: a consensus approach.
        Hum Pathol. 2002; 33: 459-465
        • Koo D.H.
        • Ryu M.H.
        • Kim K.M.
        • et al.
        Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor.
        Cancer Res Treat. 2016; 48: 1155-1166
        • Catena F.
        • Di Battista M.
        • Ansaloni L.
        • Pantaleo M.
        • Fusaroli P.
        • Di Scioscio V.
        • Santini D.
        • Nannini M.
        • Saponara M.
        • Ponti G.
        • Persiani R.
        • Delrio P.
        • Coccolini F.
        • Di Saverio S.
        • Biasco G.
        • Lazzareschi D.
        • Pinna A.
        GISTologist study group. Microscopic margins of resection influence primary gastrointestinal stromal tumor survival.
        Onkologie. 2012; 35: 645-648
        • Fusaroli P.
        • Napoleon B.
        • Gincul R.
        • et al.
        The clinical impact of ultrasound contrast agents in EUS: a systematic review according to the levels of evidence.
        Gastrointest Endosc. 2016; 84: 587-596